You are on page 1of 24

Osteoporosis

Mentor: Presentants:
dr. Kamal Adib, Sp. OT, M. Kes Jo Jonathan Jose Johan
2 DEFINITION

OSTEUS = BONES

POROUS = HAVE MANY HOLES

Disorders of bone with characteristics of decreased bone mass and micro-


architectural deterioration of bone leading to frailty and increased risk of
fracture
3

BONE
REMODELLING
4

BONE
REMODELLING
5

CALCIUM
HOMEOSTASIS
3. RISK FACTOR

UNMODIFIEABLE MODIFIEABLE
• Sex / Gender • Hormones
• Age • Diet (Calcium and Vitamin D)
• Race / Ethnic • Lifestyle
• Genetic / Family History • Smoking and Alcoholism
7 CLASSIFICATION

PRIMARY SECONDARY

Osteoporosis Type I Osteoporosis Type II • Endocrine


(Post-menopause) (Senilis)
• Malabsorption
• Drug-Induced
• Immobilization
• Smoking and Alcoholism
Menopause
Menopause

8 <<<Estrogen
Estrogen

TYPE I Bone marrow


Mononuclear
<< Ca << Ca
absorpsi reabsorpsi
OSTEOPOROSIS Stromal
mono
cell
cells + + sel
nuklear
Stromal cell
Absorption in
kalsium di usus rebsorption in
kalsium di ginjal
intestines kidneys
Osteoblasts Endothelial
Sel endotel Osteoklas
Osteoblas Osteoclasts
cells

Hipokalsemia
Hipocalcemia
IL-1,
IL TNF-α
- 1,TNF- TGF-B
TGF-β NO
NO
ILa,- IL-6 ↑
6, M-CSF
PTHPTH
secretion

diferensiasi
Osteoclasts&
maturasi osteoklas
differentiation and
maturation resorpsi
↑ Bone tulang
Resorption

Osteoporosis
Senile
<< Ca
Vitamin D defficiency absorption
9
<< Ca
TYPE II reabsorption
OSTEOPOROSIS
<< GH and << physical
<< estrogen
IGF 1 activity

hyperparathyroidism
Osteoblasts Turnover
disfunction disfunction

≫ 𝐹𝑎𝑙𝑙 𝑅𝑖𝑠𝑘𝑠
<< muscle strength

Fractur
Osteoporosis
in Children

10
PRIMARY SECONDARY
11

Immobilization
Osteogenesis
Imperfecta

Puberty disorder

Idiopathic Juvenile
Osteoporosis Malnutrition

Osteoporosis
Inflammatory cytokines
pseudoglioma
syndrome

Systemic steroids
Diagnosis

12
ANAMNESIS
13
Risk Back
Factors

Mechanism
of fractur
Hip

History of
Ilness

ASYMPTOMATIC
PHYSICAL EXAMINATION
13

Back

Hip

ASYMPTOMATIC
14 LABORATORIUM EXAMINATION

Ca
Urine

PTH TSH

Ca
Biomarker
Serum
BONE MINERAL DENSITOMETRY
15
Treatment

17
17 NON-PHARMACOLOGIC

• Reduce RISKS !!!

• Reassesment

• Lifestyle modification
18 PHARMACOLOGIC

Calcium

Calcium Carbonate, Calcium Citrate

Age Daily Calcium Intake


Recommendation (mg/day)
1-3 year 500
4-8 year 800
9-18 year 1300
19 – 50 year 1000
>50 year 1200
19 PHARMACOLOGIC

Vitamin D 400- 800 IU / day

Estherified estrogen 0.3 mg/day


Estrogen Conjugated estrogen 0.625 mg/day
20 PHARMACOLOGIC

Biphosphonat Alendronate oral 10 mg/day

Calcitonin 200 IU /day (nasal spray)


21 PHARMACOLOGIC

Sodium
Slow release, 25 mg, 2x/day
Fluoride
22 PREVENTION

• Early detection , early intervention

• Adequate Intake Calcium and vitamin D

• Exercise
Osteoporosis is not an inevitable
part of aging, it is preventable. So it
is Vital that all of us, of All Ages, start
taking care of bones now, before it is
too late

- Camillia Parker Bowles -

24

THANK YOU FOR YOUT ATTENTION

You might also like